BioScience Health Innovations Inc Financials
This page shows BioScience Health Innovations Inc (BHIC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
BioScience Health Innovations Inc has an operating margin of 4.7%, meaning the company retains $5 of operating profit per $100 of revenue. This below-average margin results in a low score of 24/100, suggesting thin profitability after operating expenses. This is up from -42.1% the prior year.
BioScience Health Innovations Inc's revenue surged 208.7% year-over-year to $1.8M, reflecting rapid business expansion. This strong growth earns a score of 100/100.
BioScience Health Innovations Inc carries a low D/E ratio of 0.05, meaning only $0.05 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
BioScience Health Innovations Inc's ROE of 10.4% shows moderate profitability relative to equity, earning a score of 42/100. This is down from 3720.4% the prior year.
BioScience Health Innovations Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, BioScience Health Innovations Inc generates $0.27 in operating cash flow ($23K OCF vs $87K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
BioScience Health Innovations Inc generated $1.8M in revenue in fiscal year 2024. This represents an increase of 208.7% from the prior year.
BioScience Health Innovations Inc reported $87K in net income in fiscal year 2024. This represents an increase of 134.6% from the prior year.
BioScience Health Innovations Inc earned $0.00 per diluted share (EPS) in fiscal year 2024. This represents an increase of 100.0% from the prior year.
BioScience Health Innovations Inc held $663K in cash against $0 in long-term debt as of fiscal year 2024.
BioScience Health Innovations Inc had 11M shares outstanding in fiscal year 2024. This represents a decrease of 73.2% from the prior year.
BioScience Health Innovations Inc's gross margin was 70.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 10.1 percentage points from the prior year.
BioScience Health Innovations Inc's operating margin was 4.7% in fiscal year 2024, reflecting core business profitability. This is up 46.8 percentage points from the prior year.
BioScience Health Innovations Inc's net profit margin was 4.7% in fiscal year 2024, showing the share of revenue converted to profit. This is up 46.8 percentage points from the prior year.
BioScience Health Innovations Inc's ROE was 10.4% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 3710.0 percentage points from the prior year.
BioScience Health Innovations Inc invested $26K in research and development in fiscal year 2024.
BHIC Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1M-35.6% | $1.8M+43.2% | $1.2M+101.1% | $610K+6.5% | $573K+49.1% | $384K+38.4% | $278K-8.6% | $304K |
| Cost of Revenue | $433K-36.6% | $683K+106.4% | $331K+22.0% | $271K+83.0% | $148K+100.9% | $74K+72.3% | $43K-36.2% | $67K |
| Gross Profit | $698K-35.0% | $1.1M+19.9% | $896K+164.3% | $339K-20.2% | $425K+36.8% | $310K+32.2% | $235K-0.7% | $237K |
| R&D Expenses | N/A | N/A | $38K | N/A | N/A | N/A | $805 | N/A |
| SG&A Expenses | $577K+6.8% | $540K+24.6% | $434K+44.4% | $300K-13.1% | $345K+55.1% | $223K-20.0% | $278K+5.0% | $265K |
| Operating Income | -$9K-101.9% | $458K+7.2% | $427K+4186.4% | $10K-82.3% | $56K-24.3% | $74K+239.0% | -$53K-39.1% | -$38K |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | -$9K-101.9% | $458K+7.2% | $427K+4186.4% | $10K-82.3% | $56K-24.3% | $74K+239.0% | -$53K-39.1% | -$38K |
| EPS (Diluted) | $0.00 | $0.010.0% | $0.01 | N/A | $0.01 | $0.00 | $0.00 | N/A |
BHIC Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.1M+0.5% | $2.1M+47.5% | $1.4M+59.6% | $874K+110.1% | $416K+94.7% | $214K+38.0% | $155K+65.8% | $93K |
| Current Assets | $2.0M+0.5% | $2.0M+48.3% | $1.3M+57.9% | $848K+107.4% | $409K+91.4% | $214K+38.0% | $155K+65.8% | $93K |
| Cash & Equivalents | $1.1M-12.3% | $1.3M+26.4% | $1.0M+55.2% | $663K+98.8% | $333K+131.5% | $144K+54.9% | $93K+383.1% | $19K |
| Inventory | $758K+204.8% | $249K+15.2% | $216K+269.9% | $58K+38.1% | $42K+4.0% | $41K+0.4% | $40K+7.2% | $38K |
| Accounts Receivable | $63K-83.8% | $390K+317.4% | $93K-6.8% | $100K+214.2% | $32K+15.5% | $28K+28.9% | $21K-41.2% | $36K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $356K+5.5% | $338K+154.0% | $133K+244.8% | $39K-15.4% | $46K+85.8% | $25K-38.6% | $40K-60.1% | $100K |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $1.7M-0.5% | $1.7M+36.3% | $1.3M+51.1% | $835K+125.6% | $370K+95.8% | $189K+64.6% | $115K+1799.1% | -$7K |
| Retained Earnings | $535K-1.6% | $543K+534.0% | $86K+125.1% | -$341K+2.8% | -$351K+13.8% | -$407K+15.4% | -$481K-12.5% | -$428K |
BHIC Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$340K-219.5% | $285K-13.2% | $328K+752.6% | -$50K-196.3% | $52K-24.6% | $69K+244.3% | -$48K+14.9% | -$56K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $0+100.0% | -$16K+46.5% | -$30K-57.9% | -$19K-170.0% | -$7K | $0 | $0 | $0 |
| Financing Cash Flow | $180K+8416.3% | $2K-96.9% | $68K-83.1% | $399K+176.6% | $144K+886.9% | -$18K-115.0% | $122K+261.2% | $34K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
BHIC Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 61.7%+0.6pp | 61.1%-11.9pp | 73.0%+17.5pp | 55.6%-18.6pp | 74.1%-6.7pp | 80.8%-3.8pp | 84.6%+6.7pp | 77.9% |
| Operating Margin | -0.8%-26.8pp | 26.0%-8.7pp | 34.8%+33.1pp | 1.6%-8.2pp | 9.8%-9.5pp | 19.3%+38.6pp | -19.2%-6.6pp | -12.6% |
| Net Margin | -0.8%-26.8pp | 26.0%-8.7pp | 34.8%+33.1pp | 1.6%-8.2pp | 9.8%-9.5pp | 19.3%+38.6pp | -19.2%-6.6pp | -12.6% |
| Return on Equity | -0.5%-27.1pp | 26.6%-7.2pp | 33.8%+32.6pp | 1.2%-14.0pp | 15.2%-24.1pp | 39.3%+85.7pp | -46.5%-614.2pp | 567.7% |
| Return on Assets | -0.4%-22.7pp | 22.3%-8.3pp | 30.6%+29.5pp | 1.1%-12.4pp | 13.5%-21.2pp | 34.8%+69.2pp | -34.5%+6.6pp | -41.1% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.21+0.0 | 0.20+0.1 | 0.11+0.1 | 0.05-0.1 | 0.120.0 | 0.13-0.2 | 0.35+15.2 | -14.81 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Frequently Asked Questions
What is BioScience Health Innovations Inc's annual revenue?
BioScience Health Innovations Inc (BHIC) reported $1.8M in total revenue for fiscal year 2024. This represents a 208.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is BioScience Health Innovations Inc's revenue growing?
BioScience Health Innovations Inc (BHIC) revenue grew by 208.7% year-over-year, from $598K to $1.8M in fiscal year 2024.
Is BioScience Health Innovations Inc profitable?
Yes, BioScience Health Innovations Inc (BHIC) reported a net income of $87K in fiscal year 2024, with a net profit margin of 4.7%.
What is BioScience Health Innovations Inc's earnings per share (EPS)?
BioScience Health Innovations Inc (BHIC) reported diluted earnings per share of $0.00 for fiscal year 2024. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is BioScience Health Innovations Inc's gross margin?
BioScience Health Innovations Inc (BHIC) had a gross margin of 70.9% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is BioScience Health Innovations Inc's operating margin?
BioScience Health Innovations Inc (BHIC) had an operating margin of 4.7% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is BioScience Health Innovations Inc's net profit margin?
BioScience Health Innovations Inc (BHIC) had a net profit margin of 4.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is BioScience Health Innovations Inc's return on equity (ROE)?
BioScience Health Innovations Inc (BHIC) has a return on equity of 10.4% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is BioScience Health Innovations Inc's operating cash flow?
BioScience Health Innovations Inc (BHIC) generated $23K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are BioScience Health Innovations Inc's total assets?
BioScience Health Innovations Inc (BHIC) had $874K in total assets as of fiscal year 2024, including both current and long-term assets.
How much does BioScience Health Innovations Inc spend on research and development?
BioScience Health Innovations Inc (BHIC) invested $26K in research and development during fiscal year 2024.
How many shares does BioScience Health Innovations Inc have outstanding?
BioScience Health Innovations Inc (BHIC) had 11M shares outstanding as of fiscal year 2024.
What is BioScience Health Innovations Inc's debt-to-equity ratio?
BioScience Health Innovations Inc (BHIC) had a debt-to-equity ratio of 0.05 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is BioScience Health Innovations Inc's return on assets (ROA)?
BioScience Health Innovations Inc (BHIC) had a return on assets of 10.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is BioScience Health Innovations Inc's Piotroski F-Score?
BioScience Health Innovations Inc (BHIC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are BioScience Health Innovations Inc's earnings high quality?
BioScience Health Innovations Inc (BHIC) has an earnings quality ratio of 0.27x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is BioScience Health Innovations Inc?
BioScience Health Innovations Inc (BHIC) scores 66 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.